Aurobindo Pharma today said it has paid $139.2 million (over Rs 600 crore) for the redemption of outstanding overseas bonds issued in 2006.
With the latest payout, the company has now paid an aggregate amount of $203.86 million for redemption of two tranches of foreign currency convertible bonds (FCCBs) issued in May, 2006, Aurobindo Pharma said in a filing to the Bombay Stock Exchange (BSE).
"Pursuant to this, all bonds issued by the company in May, 2006, have been extinguished in full and there are no outstanding as on date," it added.
After the repurchase and cancellation of FCCBs from time-to-time, the outstanding nominal value of FCCBs of $106.25 million has been paid in full at the redemption price of 146.285% of the principal amount on the maturity date, it said.
The company had issued FCCBs aggregating to $150 million in one tranche, dubbed Tranche A, on May 12, 2006.
The company has also paid $32.95 million for the redemption of FCCBs issued on May 17, 2006. The Hyderabad- based firm had issued FCCBs aggregating to $50 million in this second tranche, Tranche B.
"... The outstanding nominal value of FCCBs of $32.95 million has been paid in full at the redemption price of 146.991% of its principal amount on maturity date, May 17, 2011," the company said.
Shares of Aurobindo Pharma were being quoted at Rs 192.50 apiece on the BSE in late afternoon trade today, up 1.50% from their previous close.
